Convelo Therapeutics
Dr. Factor is a scientist with a research focus on stem cell models of development and disease. He earned his B.A. in biochemistry from Hiram College and his PhD in Genetics and Genome Sciences from Case Western Reserve University. Dr. Factor was awarded the Joy Cappel Young Investigator Award in 2014 and the Arthur F.W. Hughes Award for Developmental Biology in 2018.
Convelo Therapeutics
Convelo Therapeutics is developing a new class of medicines that unlock the regenerative capacity of the central nervous system. Convelo is pioneering approaches to regenerate the protective myelin coating around nerve cells that is lost in a wide array of neurological diseases including multiple sclerosis, pediatric leukodystrophies, traumatic injury and age-related pathologies such as Alzheimer’s. Convelo has identified key biological targets and a pipeline of drug candidates to provide novel and meaningful solutions for patients and their families.